Q32 Bio
QTTB
73 hedge funds and large institutions have $406M invested in Q32 Bio in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 8 closing their positions.
238% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 8
181% more capital invested
Capital invested by funds: $144M → $406M (+$262M)
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
35% more funds holding
Funds holding: 54 → 73 (+19)
7.98% more ownership
Funds ownership: 67.55% → 75.53% (+8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.06M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$6.98M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.4M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$3.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
-$4.52M |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$3.39M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.96M |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$832K |
| 5 |
EAM
Exome Asset Management
New York
|
-$787K |
QTTB Hedge Fund Activity: Q3 2024 in Review
73 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2024, worth a combined $406M — up 181% from $144M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new QTTB positions and 8 closed out — a net gain of 19 holders — while 19 added to existing stakes and 8 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $14.9M. The largest seller was 5AM Venture Management, exiting entirely with an estimated $4.52M sold.
- 73 institutional investors held Q32 Bio (QTTB) as of Q3 2024, up from 54 in Q2 2024.
- Funds reported $406M of Q32 Bio stock for Q3 2024, up 181% quarter-over-quarter.
- 27 funds opened new Q32 Bio positions in Q3 2024 and 8 closed out, a net change of +19 holders.
- The largest Q32 Bio buyer in Q3 2024 was Adage Capital Partners, an estimated $14.9M added.
- The largest Q32 Bio seller in Q3 2024 was 5AM Venture Management, an estimated $4.52M sold.
Based on aggregated 13F filings for Q3 2024.